Abstract
Introduction: Previous observational studies have reported inconsistent findings on the association between consumption of sugar-sweetened soft drinks (SSSDs) and the risk of gastrointestinal (GI) cancer. This study investigated the associations between SSSD consumption and the risk of GI cancer using a systematic review and meta-analysis. Methods: Observational epidemiological studies were searched from the PubMed and EMBASE databases until June 2021. We conducted a meta-analysis of all included studies and subgroup meta-analyses based on various factors. Results: In a meta-analysis of 27 studies with nine case-control studies and 18 cohort studies, the consumption of SSSDs was modestly associated with an increased risk of GI cancer (odds ratio [OR]/relative risk [RR]: 1.08; 95% confidence interval [CI]: 1.01–1.16), with a significant positive dose-response relationship. In the subgroup meta-analysis by study design, there was a significant positive association between the consumption of SSSDs and GI cancer in cohort studies (RR: 1.11; 95% CI: 1.03–1.20; n = 18), but not in case-control studies. In the subgroup meta-analysis by type of cancer, consumption of SSSDs was significantly associated with an increased risk of colorectal cancer (OR/RR: 1.13; 95% CI: 1.07–1.19). Conclusions: This meta-analysis suggests that SSSD consumption significantly increases the risk of GI cancer, specifically colorectal cancer.
Journal Section:
Clinical Study
References
1.
Globocan
Global cancer observatory: cancer today
Lyon, France
IARC
2020
. Available from: https://gco.iarc.fr/today/fact-sheets-populations (Accessed on 20th April 2021).2.
Sarfaraz
S
, Bano
T
, Fatima
W
, Amjad
R
, Mehak
A
, Iqbal
M
. Popularity of soft drinks: colored versus non-colored and risks associated with their prolonged usea
. RADS J Pharm Pharm Sci
. 2020
;5
:13
–9
.3.
US Department of Agriculture
US Department of Health and Human Services
Dietary guidelines for Americans, 2015-2020
8th edWashington, DC
US Government Printing Office
2015
.4.
White
JS
. Sucrose, HFCS, and fructose: history, manufacture, composition, applications, and production
. In: Fructose, high fructose corn syrup, sucrose and health
Humana Press
2014
. p. 13
33
.5.
Goncalves
MD
, Lu
C
, Tutnauer
J
, Hartman
TE
, Hwang
SK
, Murphy
CJ
. High-fructose corn syrup enhances intestinal tumor growth in mice
. Science
. 2019
;363
(6433
):1345
–9
.6.
Augustin
LS
, Kendall
CW
, Jenkins
DJ
, Willett
WC
, Astrup
A
, Barclay
AW
. Glycemic index, glycemic load and glycemic response: an international scientific consensus summit from the international carbohydrate quality consortium (ICQC)
. Nutr Metab Cardiovasc Dis
. 2015
;25
(9
):795
–815
.7.
Wang
J
, Lee
IM
, Tworoger
SS
, Buring
JE
, Ridker
PM
, Rosner
B
. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis
. Cancer Epidemiol Biomarkers Prev
. 2015
;24
(8
):1199
–206
.8.
Mueller
NT
, Odegaard
A
, Anderson
K
, Yuan
JM
, Gross
M
, Koh
WP
. Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study
. Cancer Epidemiol Biomarkers Prev
. 2010
;19
(2
):447
–55
.9.
Theodoratou
E
, Farrington
SM
, Tenesa
A
, McNeill
G
, Cetnarskyj
R
, Korakakis
E
. Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population
. Eur J Cancer Prev
. 2014
;23
(1
):8
–17
.10.
Hodge
AM
, Bassett
JK
, Milne
RL
, English
DR
, Giles
GG
. Consumption of sugar-sweetened and artificially sweetened soft drinks and risk of obesity-related cancers
. Public Health Nutr
. 2018
;21
(9
):1618
–26
.11.
Mack
TM
, Yu
MC
, Hanisch
R
, Henderson
BE
. Pancreas cancer and smoking, beverage consumption, and past medical history
. J Natl Cancer Inst
. 1986
;76
(1
):49
–60
.12.
Lyon
JL
, Mahoney
AW
, French
TK
, Moser
JR
. Coffee consumption and the risk of cancer of the exocrine pancreas: a case-control study in a low-risk population
. Epidemiology
. 1992
;164
:170
.13.
Schernhammer
ES
, Hu
FB
, Giovannucci
E
, Michaud
DS
, Colditz
GA
, Stampfer
MJ
. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts
. Cancer Epidemiol Biomarkers Prev
. 2005
;14
(9
):2098
–105
.14.
Nothlings
U
, Murphy
SP
, Wilkens
LR
, Henderson
BE
, Kolonel
LN
. Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the multiethnic cohort study
. Am J Clin Nutr
. 2007
;86
(5
):1495
–501
.15.
Bao
Y
, Stolzenberg-Solomon
R
, Jiao
L
, Silverman
DT
, Subar
AF
, Park
Y
. Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health–AARP Diet and Health Study
. Am J Clin Nutr
. 2008
;88
(2
):431
–40
.16.
Ibiebele
TI
, Hughes
MC
, O’Rourke
P
, Webb
PM
, Whiteman
DC
Australian Cancer Study
. Cancers of the esophagus and carbonated beverage consumption: a population-based case-control study
. Cancer Causes Control
. 2008
;19
(6
):577
–84
.17.
Chan
JM
, Wang
F
, Holly
EA
. Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study
. Cancer Causes Control
. 2009
;20
(6
):835
–46
.18.
Ren
JS
, Freedman
ND
, Kamangar
F
, Dawsey
SM
, Hollenbeck
AR
, Schatzkin
A
. Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study
. Eur J Cancer
. 2010
;46
(10
):1873
–81
.19.
Zhang
X
, Albanes
D
, Beeson
WL
, Van Den Brandt
PA
, Buring
JE
, Flood
A
. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies
. J Natl Cancer Inst
. 2010
;102
(11
):771
–83
.20.
Genkinger
JM
, Li
R
, Spiegelman
D
, Anderson
KE
, Albanes
D
, Bergkvist
L
. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies
. Cancer Epidemiol Biomarkers Prev
. 2012
;21
(2
):305
–18
.21.
Wang
Z
, Uchida
K
, Ohnaka
K
, Morita
M
, Toyomura
K
, Kono
S
. Sugars, sucrose and colorectal cancer risk: the Fukuoka colorectal cancer study
. Scand J Gastroenterol
. 2014
;49
(5
):581
–8
.22.
Navarrete-Munoz
EM
, Wark
PA
, Romaguera
D
, Bhoo-Pathy
N
, Michaud
D
, Molina-Montes
E
. Sweet-beverage consumption and risk of pancreatic cancer in the European prospective investigation into cancer and nutrition (EPIC)
. Am J Clin Nutr
. 2016
;104
(3
):760
–8
.23.
Makarem
N
, Bandera
EV
, Lin
Y
, Jacques
PF
, Hayes
RB
, Parekh
N
. Consumption of sugars, sugary foods, and sugary beverages in relation to adiposity-related cancer risk in the Framingham Offspring Cohort (1991–2013)
. Cancer Prev Res
. 2018
;11
(6
):347
–58
.24.
Chazelas
E
, Srour
B
, Desmetz
E
, Kesse Guyot
E
, Julia
C
, Deschamps
V
. Sugary drink consumption and risk of cancer: results from NutriNet-Sante prospective cohort
. Br Med J
. 2019
366
l2408
.25.
Malik
VS
, Li
Y
, Pan
A
, De Koning
L
, Schernhammer
E
, Willett
WC
. Long-term consumption of sugar-sweetened and artificially sweetened beverages and risk of mortality in US adults
. Circulation
. 2019
;139
(18
):2113
–25
.26.
Mullee
A
, Romaguera
D
, Pearson-Stuttard
J
, Viallon
V
, Stepien
M
, Freisling
H
. Association between soft drink consumption and mortality in 10 European countries
. JAMA Intern Med
. 2019
;179
(11
):1479
–90
.27.
Pacheco
LS
, Anderson
CA
, Lacey
JV
Jr, Giovannucci
EL
, Lemus
H
, Araneta
MR
. Sugar-sweetened beverages and colorectal cancer risk in the California teachers study
. PLoS One
. 2019
;14
(10
):e0223638
.28.
Wells
G
, Shea
B
, O’connell
D
, Peterson
J
, Welch
V
, Losos
M
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
Ott. Hosp. Res. Inst
2014
. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.29.
Higgins
JP
, Thompson
SG
. Quantifying heterogeneity in a meta-analysis
. Stat Med
. 2002
;21
(11
):1539
–58
.30.
DerSimonian
R
, Kacker
R
. Random-effects model for meta-analysis of clinical trials: an update
. Contemp Clin Trials
. 2007
;28
(2
):105
–14
.31.
Macaskill
P
, Walter
SD
, Irwig
L
. A comparison of methods to detect publication bias in meta-analysis
. Stat Med
. 2001
;20
(4
):641
–54
.32.
Moher
D
, Liberati
A
, Tetzlaff
J
, Altman
DG
PRISMA Group
. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
. PLoS Med
. 2009
;6
(7
):e1000097
.33.
Touvier
MK-GE
, Kesse-Guyot
E
, Méjean
C
, Pollet
C
, Malon
A
, Castetbon
K
. Comparison between an interactive web-based self administered 24 h dietary record and an interview by a dietitian for large-scale epidemiological studies
. Br J Nutr
. 2011
;105
(7
):1055
–64
.34.
DiMeglio
DP
, Mattes
RD
. Liquid versus solid carbohydrate: effects on food intake and body weight
. Int J Obes Relat Metab Disord
. 2000
;24
(6
):794
–800
.35.
World Cancer Research Fund International
Diet, nutrition, physical activity and cancer: a global perspective: a summary of the third expert report
World Cancer Research Fund International
2018
. Available from: https://www.wcrf.org/sites/default/files/Summary-third-expert-report.pdf (Accessed on 12th May 2021).36.
Ma
J
, McKeown
NM
, Hwang
SJ
, Hoffmann
U
, Jacques
PF
, Fox
CS
. Sugar-sweetened beverage consumption is associated with change of visceral adipose tissue over 6 years of follow-up
. Circulation
. 2016
;133
(4
):370
–7
.37.
Maersk
M
, Belza
A
, Stodkilde-Jorgensen
H
, Ringgaard
S
, Chabanova
E
, Thomsen
H
. Sucrose sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study
. Am J Clin Nutr
. 2012
;95
(2
):283
–9
.38.
Stanhope
KL
, Schwarz
JM
, Keim
NL
, Griffen
SC
, Bremer
AA
, Graham
JL
. Consuming fructose sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
. J Clin Invest
. 2009
;119
(5
):1322
–34
.39.
Doyle
SL
, Donohoe
CL
, Lysaght
J
, Reynolds
JV
. Visceral obesity, metabolic syndrome, insulin resistance and cancer
. Proc Nutr Soc
. 2012
;71
(1
):181
–9
.40.
Liu
S
, Manson
JE
, Buring
JE
, Stampfer
MJ
, Willett
WC
, Ridker
PM
. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle aged women
. Am J Clin Nutr
. 2002
;75
(3
):492
–8
.41.
Rajendran
P
, Rengarajan
T
, Thangavel
J
, Nishigaki
Y
, Sakthisekaran
D
, Sethi
G
. The vascular endothelium and human diseases
. Int J Biol Sc
. 2013
;9
(10
):1057
–69
.42.
Uribarri
J
, Stirban
A
, Sander
D
, Cai
W
, Negrean
M
, Buenting
CE
. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects
. Diabetes Care
. 2007
;30
(10
):2579
–82
.43.
Turati
F
, Galeone
C
, Gandini
S
, Augustin
LS
, Jenkins
DJA
, Pelucchi
C
. High glycemic index and glycemic load are associated with moderately increased cancer risk
. Mol Nutr Food Res
. 2015
;59
(7
):1384
–94
.44.
Tzatzarakis
MN
, Vakonaki
E
, Moti
S
, Alegakis
A
, Tsitsimpikou
C
, Tsakiris
I
. Quantification of 4-Methylimidazole in soft drinks, sauces and vinegars of Greek market using two liquid chromatography techniques
. Food Chem Toxicol
. 2017
107
Pt B
565
71
.45.
Morita
T
, Uneyama
C
. Genotoxicity assessment of 4-methylimidazole: regulatory perspectives
. Genes Environ
. 2016
;38
:20
.46.
International Agency for Research on Cancer
. 4-Methylimidazole
. In IARC monographs on the evaluation of carcinogenic risks to humans volume 101: some chemicals present in industrial and consumer products, food and drinking-water
. 2013
. Available from: https://monographs.iarc.fr/ENG/Monographs/vol101/mono101-015.pdf.47.
Boyle
P
, Koechlin
A
, Autier
P
. Sweetened carbonated beverage consumption and cancer risk: meta-analysis and review
. Eur J Cancer Prev
. 2014
;23
(5
):481
–90
.48.
Milajerdi
A
, Larijani
B
, Esmaillzadeh
A
. Sweetened beverages consumption and pancreatic cancer: a meta-analysis
. Nutr Cancer
. 2019
;71
(3
):375
–84
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
